How the pharmacokinetics and receptor-binding profile of lurasidone affect the clinical utility and safety of the drug in the treatment of schizophrenia-Reference-Cited by-同舟云学术

How the pharmacokinetics and receptor-binding profile of lurasidone affect the clinical utility and safety of the drug in the treatment of schizophrenia

Published:2015-07-14 Issue:8 Volume:11 Page:1317-1327
ISSN:1742-5255
Container-title:Expert Opinion on Drug Metabolism & Toxicology
language:en
Short-container-title:Expert Opinion on Drug Metabolism & Toxicology

Author:

Macaluso Matthew,Kazanchi Hala,Preskorn Sheldon H

Publisher

Informa Healthcare

Subject

Pharmacology,Toxicology,General Medicine

Link

http://www.tandfonline.com/doi/pdf/10.1517/17425255.2015.1059821

Reference21 articles.

1. The Evolution of Antipsychotic Drug Therapy: Reserpine, Chlorpromazine, and Haloperidol

2. Lurasidone for Schizophrenia: A Brief Review of a New Second-Generation Antipsychotic

3. Pharmacological Profile of Lurasidone, a Novel Antipsychotic Agent with Potent 5-Hydroxytryptamine 7 (5-HT7) and 5-HT1A Receptor Activity

4. Lurasidone (SM-13496), a novel atypical antipsychotic drug, reverses MK-801-induced impairment of learning and memory in the rat passive-avoidance test

5. Lurasidone for schizophrenia: a review of the efficacy and safety profile for this newly approved second-generation antipsychotic

Cited by 2 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Safety and effectiveness of lurasidone in the treatment of Chinese schizophrenia patients: An interim analysis of post-marketing surveillance;World Journal of Psychiatry;2023-11-19

2. Sustained Impairment of Lurasidone Clearance After Discontinuation of Posaconazole;Journal of Clinical Psychopharmacology;2018-08